AiCure is revolutionizing clinical trials for medicine
Clinical trials for new drug development are time consuming and expensive. It is hard to get participants to join drug trials, to participate fully and to stay in once they are in. This means that clinical trials for new drug development are time consuming and expensive. Which leads to fewer drugs coming to market at more expensive prices.
In this podcast AiCure’s President and Chief Medical Officer, Ed Ikeguchi, explains how AiCure is looking to fundamentally change this entire paradigm through the application of AI. This is a fascinating story and a good look into how AI can dramatically impact healthcare and medicine.